Connecticut General Statutes
Chapter 400j - Pharmacy
Section 20-574. (Formerly Sec. 20-164a). - Supervision by Commissioner of Consumer Protection.

The commissioner shall exercise supervision over the operations of the commission pursuant to sections 20-570 to 20-630, inclusive.

(1959, P.A. 412, S. 30; P.A. 77-614, S. 198, 610; P.A. 95-264, S. 5; P.A. 99-175, S. 9; P.A. 16-185, S. 43.)
History: P.A. 77-614 deleted statement placing commission within consumer protection department “for fiscal and budgetary purposes”, effective January 1, 1979; P.A. 95-264 made technical change; Sec. 20-164a transferred to Sec. 20-574 in 1997; P.A. 99-175 made technical changes and replaced reference to Sec. 20-625 with reference to Sec. 20-630; P.A. 16-185 deleted “general”, effective July 1, 2016.
Commissioner has the authority to review defendant pharmacy's billing records. 53 CA 129.

<< Previous
Next >>

Structure Connecticut General Statutes

Connecticut General Statutes

Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards

Chapter 400j - Pharmacy

Section 20-570. - Short title: Pharmacy Practice Act.

Section 20-571. (Formerly Sec. 20-184a). - Definitions.

Section 20-572. (Formerly Sec. 20-163). - Commission of Pharmacy. Appointment and term of members.

Section 20-573. (Formerly Sec. 20-165). - Meetings of commission. Records.

Section 20-574. (Formerly Sec. 20-164a). - Supervision by Commissioner of Consumer Protection.

Section 20-575. - Powers and responsibilities.

Section 20-576. (Formerly Sec. 20-164). - Regulations.

Section 20-576a. - Acceptance and disposal of unused prescription drugs at pharmacies. Regulations.

Section 20-577. (Formerly Sec. 20-179). - Employment of inspectors by Commissioner of Consumer Protection; duties. Inspection of correctional, juvenile training and care-giving institutions, dispensing outpatient facilities, institutional and retail...

Section 20-578. (Formerly Sec. 21a-306). - Information not to be disclosed. Exception.

Section 20-579. (Formerly Sec. 20-175). - Causes for suspension, revocation, refusal to issue or renew or the placing of conditions on licenses, temporary permits and registrations and for assessment of civil penalty.

Section 20-580. (Formerly Sec. 20-167). - Revocation or suspension of nonlegend drug permit.

Section 20-581. (Formerly Sec. 20-185). - Penalty for violation of Pharmacy Practice Act. Exception.

Section 20-582. (Formerly Sec. 20-176). - Appeals of decisions of Commission of Pharmacy.

Section 20-583. - Where appeals returnable.

Section 20-590. (Formerly Sec. 20-170). - Issuance of license or temporary permit to practice pharmacy; requirements.

Section 20-591. - Graduates of foreign pharmacy schools. Regulations.

Section 20-592. - Licensure of individual who is a licensed pharmacist in another state or jurisdiction.

Section 20-593. (Formerly Sec. 20-172). - Pharmacist license certificate; expiration; renewal; fee; display document.

Section 20-594. (Formerly Sec. 20-168). - Pharmacy license; application; information required; issuance or renewal of license; expiration. Transfer of pharmacy to new location. Report re administrative or legal action.

Section 20-595. (Formerly Sec. 20-168a). - Pharmacy licenses held by corporations. Notice of change in officers or directors.

Section 20-596. (Formerly Sec. 20-168b). - Ownership of pharmacies by prescribing practitioners.

Section 20-597. (Formerly Sec. 20-169). - Pharmacy to be supervised and managed by pharmacist. Regulations re prescription department. Change in management, ownership or name of pharmacy.

Section 20-598. (Formerly Sec. 20-177). - Registration of pharmacy interns.

Section 20-598a. - Registration and certification of pharmacy technicians.

Section 20-599. (Formerly Sec. 20-174a). - Continuing education: Definitions.

Section 20-600. (Formerly Sec. 20-174b). - Continuing education: Requirements; renewal of licenses; regulations.

Section 20-601. - Fees.

Section 20-605. - Practice of pharmacy without license or temporary permit prohibited.

Section 20-606. (Formerly Sec. 20-178). - Use of the title “pharmacist”.

Section 20-607. (Formerly Sec. 20-173). - Certificate of license, temporary permit or registration to be available for inspection.

Section 20-608. (Formerly Sec. 20-174). - Use of certificate of license, temporary permit or display document by unlicensed person prohibited.

Section 20-609. (Formerly Sec. 20-184). - Pharmacy license to be posted. Business which is not a pharmacy prohibited from using words, displays or symbols indicating it is a pharmacy; exemption.

Section 20-609a. - Use of electronic technology or telepharmacy by hospital. Quality assurance evaluations.

Section 20-610. (Formerly Sec. 20-166). - Dispensing or retail sale of legend drugs, legend devices and certain other drugs by other than pharmacies and hospitals, prohibited.

Section 20-611. (Formerly Sec. 20-175b). - Advertising legend drug prices.

Section 20-612. - Only pharmacy may accept prescription for dispensing.

Section 20-612a. - Confirmation of identification prior to release of controlled substance. Exceptions.

Section 20-613. (Formerly Sec. 21a-308). - Dispensing of drug or legend device pursuant to prescription only; exceptions. Emergency dispensing of drug or device in care-giving, correctional or juvenile training institutions; regulations. Pharmacy tec...

Section 20-613a. - Requests for controlled substance issued on results of answers to electronic questionnaire. Regulations.

Section 20-614. (Formerly Sec. 20-184b). - Prescriptions: Form and content. Offer to consult with pharmacist. Electronic data intermediaries.

Section 20-615. (Formerly Sec. 20-184c). - Prescriptions: Pharmacy to assign serial number and maintain records. Transfer of records to another pharmacy.

Section 20-616. (Formerly Sec. 20-184d). - Prescription refills and transfers. Thirty-day supply of diabetes drugs and devices. Notice to prescribing practitioner. Payment. Referral to federally-qualified health center.

Section 20-616a. - Prescription refills for quantity of drug greater than initial quantity prescribed. Conditions.

Section 20-617. (Formerly Sec. 20-184e). - Prescriptions: Notation of drug quantity, expiration date, generic name and drug manufacturer and MedWatch program information. Label information for generic drug substitutions.

Section 20-617a. - Flavoring agent added to prescription product.

Section 20-618. (Formerly Sec. 21a-107). - Repackaged drugs not considered misbranded, when.

Section 20-619. (Formerly Sec. 20-185a). - Substitution of generic drugs and biological products. Definitions. Interchangeable biological products. Prescribing practitioners. Pharmacy signs. Dispensing. Records. Regulations.

Section 20-619a. - Biological product prescribing. Prescribing practitioner discussion with patient or representative. Documentation. Patient request to sign for delivery.

Section 20-620. (Formerly Sec. 20-185g). - Pharmacist's duties towards Medicaid recipients: To obtain, record and maintain pertinent patient information about the recipient; to undertake a review of the drugs previously dispensed to the recipient and...

Section 20-621. (Formerly Sec. 20-185h). - Relabeling and dispensing of parenteral medication in hospital and nursing home pharmacies: When allowed.

Section 20-621a. - Use of automated prescription dispensing machine in long-term care pharmacies authorized. Regulations.

Section 20-622. (Formerly Sec. 20-180a). - Licensed practitioners may authorize medication to be dispensed from a hospital emergency room.

Section 20-623. - Sale of nonlegend drugs. Labels, packaging and contents. Penalty.

Section 20-624. - Permit to sell nonlegend drugs.

Section 20-625. - Nonlegend veterinary drugs.

Section 20-626. - Confidentiality of pharmacy records.

Section 20-627. - Nonresident pharmacy. Definitions. Certificate of registration. Requirements.

Section 20-628. - Shipping, mailing or delivering legend devices or drugs.

Section 20-629. - Denial, revocation or suspension of nonresident pharmacy certificate of registration. Referral by commission.

Section 20-630. - Advertising.

Section 20-631. - Collaborative drug therapy management agreements between pharmacists and physicians or advanced practice registered nurses. Scope. Pharmacist competency requirements. Regulations.

Section 20-631a. - Collaborative drug management agreements between pharmacists employed by community pharmacies and one or more physicians or advanced practice registered nurses. Pilot program.

Section 20-631b. - Collaborative drug therapy management agreements entered into prior to October 1, 2010.

Section 20-632. - Regulatory action report re disciplinary action against persons with controlled substance registrations and sanctions against pharmacists or pharmacies.

Section 20-633. - Administration of vaccines by licensed pharmacists. Regulations.

Section 20-633a. - Pharmacy rewards program. Plain language summary. Violation.

Section 20-633b. - Sterile compounding pharmacies. Requirements. Regulations.

Section 20-633c. - Prescribing of opioid antagonists by licensed pharmacists. Regulations.

Section 20-633d. - Medical protocol standing order for dispensing of opioid antagonists by licensed pharmacists. Regulations.

Section 20-633e. - Pharmacy and institutional pharmacy perpetual inventory of Schedule II controlled substances. Regulations.

Section 20-633i. - Issuance of prescriptions for epinephrine auto injectors by pharmacists.

Section 20-635. - Prescription error reporting. Definitions. Informational signs and statements. Regulations. Nondisclosure of records.

Section 20-636. - Sign re storage and disposal of prescription drugs.